| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1111776150 |
| P356 | DOI | 10.1186/S12933-019-0817-1 |
| P932 | PMC publication ID | 6352423 |
| P698 | PubMed publication ID | 30700294 |
| P2093 | author name string | Kerry Mills | |
| Yu Cao | |||
| Yan Li | |||
| Hua Huang | |||
| Lihong Jiang | |||
| Yu Xu | |||
| Rongzhong Huang | |||
| Zicheng Hu | |||
| Julio Romero | |||
| P2860 | cites work | The metabolic syndrome--a new worldwide definition | Q29615125 |
| Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus | Q31966638 | ||
| Efficacy of pioglitazone on glycemic control and carotid intima-media thickness in type 2 diabetes patients with inadequate insulin therapy | Q33558402 | ||
| Effect of acarbose to delay progression of carotid intima-media thickness in early diabetes | Q33773432 | ||
| Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study | Q34097974 | ||
| Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data | Q34249847 | ||
| Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. | Q34477625 | ||
| Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial | Q34572519 | ||
| Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study | Q34786567 | ||
| Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials | Q35210575 | ||
| Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis | Q35784692 | ||
| The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial | Q36063048 | ||
| Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes | Q77878212 | ||
| Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study | Q80183412 | ||
| Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control | Q81301669 | ||
| Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials | Q82121812 | ||
| Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia | Q84691196 | ||
| Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy | Q86492891 | ||
| Variation of Carotid Intima Media Thickness With Body Mass Index in Healthy Adults of Black African Descent | Q88674361 | ||
| Impact of sitagliptin on carotid intima-media thickness in patients with coronary artery disease and impaired glucose tolerance or mild diabetes mellitus. | Q50468728 | ||
| Effect of alpha-glucosidase inhibitors on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. | Q51164823 | ||
| Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. | Q51477941 | ||
| Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy. | Q52598205 | ||
| Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy study from the Honolulu Heart Program. | Q52884962 | ||
| Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. | Q53447391 | ||
| Candesartan- and Atenolol-Based Treatments Induce Different Patterns of Carotid Artery and Left Ventricular Remodeling in Hypertension | Q57315910 | ||
| Letter by Rundek et al Regarding Article, “Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis” | Q58770694 | ||
| Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study | Q71774494 | ||
| Carotid intima-media thickness in hyperlipidemic type I and type II diabetic patients | Q73112425 | ||
| The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse | Q73138330 | ||
| Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes | Q73447648 | ||
| Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent | Q74288448 | ||
| Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study | Q74507662 | ||
| Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes | Q74555870 | ||
| Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation | Q74565883 | ||
| The metabolic syndrome: a concept hard to define | Q36144453 | ||
| Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study | Q37167569 | ||
| Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis | Q37748176 | ||
| Carotid intima–media thickness: a suitable alternative for cardiovascular risk as outcome? | Q37875039 | ||
| Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials | Q38055275 | ||
| The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial | Q38373032 | ||
| The effect of losartan and amlodipine on left ventricular diastolic function and atherosclerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study | Q38497180 | ||
| Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with establis | Q38498458 | ||
| The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation | Q38934653 | ||
| Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus | Q40102509 | ||
| Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial | Q40944104 | ||
| A primer on network meta-analysis with emphasis on mental health. | Q41019722 | ||
| Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). | Q41080253 | ||
| Changes in carotid intima-media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation. | Q42318780 | ||
| Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). | Q43562626 | ||
| Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries | Q43635198 | ||
| Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study | Q43646061 | ||
| Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus | Q43664861 | ||
| Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes | Q43666606 | ||
| Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients | Q43717176 | ||
| Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery | Q43774118 | ||
| Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. | Q43843095 | ||
| Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study | Q43874128 | ||
| Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). | Q43890114 | ||
| A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes | Q43949014 | ||
| Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes. | Q44329366 | ||
| Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus | Q44786820 | ||
| Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance | Q44836881 | ||
| Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients | Q45064729 | ||
| Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease | Q45161573 | ||
| Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients. | Q45220100 | ||
| Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria | Q45251452 | ||
| Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F. | Q45277132 | ||
| Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury. | Q45935403 | ||
| Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). | Q45992182 | ||
| Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes | Q46083123 | ||
| Body mass index as a determinant of carotid intima-media thickness in Nigerian adults with primary hypertension | Q46173242 | ||
| Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study | Q46174552 | ||
| Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus | Q46191136 | ||
| Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study | Q46481435 | ||
| Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea | Q46499787 | ||
| Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy | Q46612613 | ||
| Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes | Q47223795 | ||
| Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q47381195 | ||
| Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE). | Q48103910 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intima-media thickness | Q2698596 |
| P304 | page(s) | 14 | |
| P577 | publication date | 2019-01-30 | |
| P1433 | published in | Cardiovascular Diabetology | Q2468083 |
| P1476 | title | Comparative effects of lipid lowering, hypoglycemic, antihypertensive and antiplatelet medications on carotid artery intima-media thickness progression: a network meta-analysis | |
| P478 | volume | 18 |
Search more.